CellCarta Acquires Biogazelle

Biogazelle offers expert laboratory services in nucleic acid quantification (gene expression, mutation, and copy number analysis, antisense oligonucleotide screening) to support its customers in their development of diagnostics and therapeutics. Customized workflows for clinically relevant samples from liquid biopsies to fixed tissues are available. In addition, the company's advanced RNA biomarker development program offers an end-to-end solution from RNA biomarker panel discovery (including liquid biopsies) to the development of a PCR-based molecular diagnostic test. it also serves as a specialty lab in the field of clinical trials and in routine diagnostic settings. Biogazelle was formed in 2007 and is based in Zwijnaarde, Belgium.